Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14701263 | 0.83 | MAPT (0.57) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL21037003 | 0.82 | MEN1 (0.50) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL14701166 | 0.81 | MAPT (0.60) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL14703188 | 0.81 | MAPT (0.48) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL14701235 | 0.80 | MAPT (0.46) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL15493909 | 0.79 | ALDH1A1 (0.43) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL14701167 | 0.79 | MAPT (0.58) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL14701244 | 0.78 | SLC16A3 (0.45) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL11436185 | 0.77 | ALDH1A1 (0.53) | MAPTALDH1A1KMT2AMEN1POLB | |
| SCHEMBL9494350 | 0.75 | MEN1 (0.64) | MAPTALDH1A1KMT2AMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8664289-B2 | Dye and coloring photosensitive composition | ADEKA CORPORATION (JP) | 2014-03-04 | — | — | US | disclosed |
| US-8664289-B2 | Dye and coloring photosensitive composition | ADEKA CORPORATION (JP) | 2014-03-04 | — | — | US | disclosed |
| US-20130041062-A1 | DYE AND COLORING PHOTOSENSITIVE COMPOSITION | ADEKA CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20130041062-A1 | DYE AND COLORING PHOTOSENSITIVE COMPOSITION | ADEKA CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130041062-A1 | DYE AND COLORING PHOTOSENSITIVE COMPOSITION | IK, CRY1, ABCG2 | MAPT 458/4885ALDH1A1 155/4885KMT2A 3478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.